ArticleInvestigative and clinical urology2024

Risk factors for failing to complete gemcitabine-cisplatin neoadjuvant chemotherapy in muscle invasive bladder cancer patients.

Homin Kang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.